To see the efficacy of deep transcranial magnetic stimulation (type of non-invasive neuromodulation) in treatment of patients with somatic symptom disorder.

A double blind randomised sham controlled study for effect of deep repetitive transcranial magnetic stimulation in treatment of patients with somatic symptom disorder

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/073038

Enrollment

Registered

2024-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F450- Somatization disorder

Interventions

Intervention1: Repetitive Transcranial Magnetic Stimulation (rTMS): Treatment group will receive 15 sessions of rTMS. one session/day for 15 days. Each session lasting 18 minutes. Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Somatic Symptom Disorder (SSD) according to DSM-5 criteria. Age :- 18 - 50 years Either gender Registered at AIIMS Psychiatry OPD Patients willing to give consent for the study Poor response to pharmacotherapy

Exclusion criteria

Exclusion criteria: Significant comorbid psychiatric disorders Significant medical comorbidity History suggestive of seizures, space occupying brain lesions or cerebrovascular accidents Implanted device or cardiac pacemaker History of neuromodulation including modified Electroconvulsive therapy (mECT) in the last 6 months. Has received analgesics for a prolonged period of time

Design outcomes

Primary

Measure	Time frame
to assess improvement in somatic symptomsTimepoint: at baseline and 3 weeks (post rTMS)	—

Secondary

Measure	Time frame
to assess improvement in anxiety & depressive symptoms, quality of life & socio-occupational functioningTimepoint: at baseline & 3 weeks (post rTMS)	—

Countries

India

Contacts

Public ContactSrijana bhatta

AIIMS New Delhi

nandkm2001@gmail.com9899943146

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026